Compounds for the treatment of metabolic disorders

The present invention is directed to therapeutic compounds of the following formula (I) which have activity as agonists of GPR119 and are useful for the treatment of metabolic disorders including type II diabetes.

Saved in:
Bibliographic Details
Main Authors FYFE, MATTHEW COLIN THOR, WITHALL, DAVID MATTHEW, JEEVARATNAM, REVATHY PERPETUA, SCHOFIELD, KAREN LESLEY, STAROSKE, THOMAS, KRULLE, THOMAS MARTIN, STEWART, ALAN JOHN WILLIAM, STONEHOUSE, DAVID FRENCH, SMYTH, DONALD, SWAIN, SIMON ANDREW, BARBA, OSCAR, DUPREE, TOM BANKSIA, FRY, PETER TIMOTHY
Format Patent
LanguageEnglish
Published 03.11.2011
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention is directed to therapeutic compounds of the following formula (I) which have activity as agonists of GPR119 and are useful for the treatment of metabolic disorders including type II diabetes.
Bibliography:Application Number: AU20100222672